Clinical trial

To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg

NCT00946725

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-11-01

PhasePHASE1

Study timeline

Study start (unknown)2000-11-01Date precision: month

Registry last updated2017-03-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Anginaunresolved

Hypertensionunresolved

Interventions

Atenolol (Tenormin) 100 mg Tablets Zeneca (Astra Zeneca Pharmaceutical)DRUG

Atenolol 100 mg Tablets (Geneva Pharmaceutical, Inc.)DRUG

Sponsors & collaborators

Sandozlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00946725 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.